Evaluate PRME stock safety — financial health, volatility, institutional backing, and risk factors.

What are the risks of investing in PRME? | Glauxie AI

Q: What are the risks of investing in PRME?

Prime Medicine, Inc. (PRME) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Allan Reine. Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address diseases by deploying gene editing technology. It offers Prime Editors with a Prime Editor protein, comprising a... Employees: 100,000.

Q: How much debt does PRME have?

Review PRME total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Q: Is PRME a good long-term investment?

Evaluate PRME as a long-term investment using fundamental scores, growth metrics, and risk assessment.

What are the risks of investing in PRME?

🦉

Prime Medicine, Inc. (PRME)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOAllan Reine

Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address diseases by deploying gene editing technology. It offers Prime Editors with a Prime Editor protein, comprising a fusion between a Cas protein and a reverse transcriptase enzyme; and a pegRNA, which targets the...

Key Executives

Name	Title
Allan Reine	Chief Executive Officer & Director
Andrew Anzalone	Co-Founder
Ann L. Lee	Chief Technical Officer
David R. Liu	Co-Founder & Member of Scientific Advisory Board
Jeffrey D. Marrazzo	Executive Chair
Keith Michael Gottesdiener	Consultant

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

PRME Profile Financials

Is PRME stock safe? How much debt does PRME have? Is PRME a good long-term investment?